What is the official website of Molecular Devices ?

The official website of Molecular Devices is https://www.moleculardevices.com.

What is Molecular Devices's cybersecurity risk score?

Molecular Devices has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Molecular Devices experienced?

According to Rankiteo, Molecular Devices currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Molecular Devices been affected by any supply chain cyber incidents ?

According to Rankiteo, Molecular Devices has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Molecular Devices have SOC 2 Type 1 certification ?

According to Rankiteo, Molecular Devices is not certified under SOC 2 Type 1.

Does Molecular Devices have SOC 2 Type 2 certification ?

According to Rankiteo, Molecular Devices does not hold a SOC 2 Type 2 certification.

Does Molecular Devices comply with GDPR ?

According to Rankiteo, Molecular Devices is not listed as GDPR compliant.

Does Molecular Devices have PCI DSS certification ?

According to Rankiteo, Molecular Devices does not currently maintain PCI DSS compliance.

Does Molecular Devices comply with HIPAA ?

According to Rankiteo, Molecular Devices is not compliant with HIPAA regulations.

Does Molecular Devices have ISO 27001 certification ?

According to Rankiteo,Molecular Devices is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Molecular Devices operate in ?

Molecular Devices operates primarily in the Biotechnology Research industry.

How many employees does Molecular Devices have ?

Molecular Devices employs approximately 745 people worldwide.

Does Molecular Devices own any subsidiaries ?

Molecular Devices presently has no subsidiaries across any sectors.

How many LinkedIn followers does Molecular Devices have ?

Molecular Devices's official LinkedIn profile has approximately 43,965 followers.

What is the NAICS classification code for Molecular Devices ?

Molecular Devices is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Molecular Devices have a Crunchbase profile ?

No, Molecular Devices does not have a profile on Crunchbase.

Does Molecular Devices have a LinkedIn profile ?

Yes, Molecular Devices maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/molecular-devices.

How many cybersecurity incidents has Molecular Devices experienced ?

As of July 22, 2026, Rankiteo reports that Molecular Devices has not experienced any cybersecurity incidents.

How many peer or competitor companies does Molecular Devices have ?

Molecular Devices has an estimated 4,731 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Molecular Devices

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

Molecular Devices Vendor Cyber Rating & Cyber Score

moleculardevices.com

Add Your Compliance Badge

Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class

Molecular Devices A.I CyberSecurity Scoring

Scoring History

Molecular Devices

Molecular Devices CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Molecular Devices Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Molecular Devices

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Molecular Devices in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Molecular Devices in 2026.

Incident Types Molecular Devices vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Molecular Devices in 2026.

Incident History - Molecular Devices (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Molecular Devices Subsidiaries

Molecular Devices

Biotechnology Research

Website: https://www.moleculardevices.com

Company Size: 745

Danaher CorporationMedical Equipment Manufacturing

Beckman Coulter DiagnosticsMedical Equipment Manufacturing

Beckman Coulter Dx North AmericaMedical Equipment Manufacturing

Beckman Coulter Dx BrasilFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Beckman Coulter Dx EEMEAتصنيع المعدات الطبية

Beckman Coulter Dx LATAMFabricação de instrumentos e materiais para uso médico e odontológico e de artigos ópticos

Beckman Coulter Dx Asia PacificMedical Equipment Manufacturing

한국벡크만쿨터의료장비 제조

Pall CorporationManufacturing

Pall - Energy+Machinery Manufacturing

Aria FiltraEnvironmental Services

Pall - Food & BeverageFood and Beverage Services

Pall - AerospaceAviation and Aerospace Component Manufacturing

Pall - Energy+Machinery Manufacturing

Pall - MicroelectronicsAppliances, Electrical, and Electronics Manufacturing

CytivaBiotechnology Research

Pall Medical, part of CytivaMedical Equipment Manufacturing

Cytiva LATAMPesquisa biotecnológica

CepheidBiotechnology Research

Leica MicrosystemsMedical Equipment Manufacturing

Leica Microsystems MedicalHospitals and Health Care

Leica BiosystemsMedical Device

Leica Biosystems EMEAMedical Equipment Manufacturing

Beckman Coulter Life SciencesBiotechnology Research

Beckman Coulter Life Sciences India, SWA, METAIBiotechnology Research

Beckman Coulter Life Sciences BrazilBiotechnology Research

Beckman Coulter Life Sciences TASK RegionBiotechnology Research

Beckman Coulter Life Sciences LATAMBiotechnology Research

Beckman Coulter Life Sciences - China生物技术研究

Beckman Coulter Life Sciences RussiaИсследования в сфере биотехнологий

Integrated DNA TechnologiesBiotechnology Research

CRISPR genome editing by IDTBiotechnology Research

SCIEXBiotechnology Research

SCIEX Food & Environmental Testing SolutionsBiotechnology Research

SCIEX Biopharma & Pharma SolutionsBiotechnology Research

SCIEX Omics SolutionsBiotechnology

SCIEX Forensic Testing SolutionsBiotechnology Research

SCIEX Service & SupportMedical Equipment Manufacturing

SCIEX Clinical ApplicationsMedical Equipment Manufacturing

SCIEX LatinoaméricaPesquisa biotecnológica

RadiometerMedical Equipment Manufacturing

AbcamBiotechnology Research

PhenomenexBiotechnology Research

Phenomenex - EMEABiotechnology

Danaher Life SciencesBiotechnology Research

Beckman Coulter Diagnostics EuropeMedical Equipment Manufacturing

MammotomeMedical Equipment Manufacturing

AldevronBiotechnology Research

GenedataBiotechnology Research

ジーンデータ（株）/ Genedata KKバイオテクノロジー研究

IDBSSoftware Development

PolarSoftware Development

HemoCue ABMedical Equipment Manufacturing

Beckman Coulter Dx India & SWAMedical Equipment Manufacturing

Beckman Coulter Dx TurkeyTıbbi Ekipman İmalatı

Beckman Coulter Dx Eastern EuropeVýroba zdravotnických prostředků

Danaher India Development CenterIT System Custom Software Development

Beckman Coulter Dx China生物技术研究

Danaher DiagnosticsMedical Equipment Manufacturing

Clone Screening | Molecular DevicesBiotechnology Research

FLIPR Penta Drug Screening | Molecular DevicesBiotechnology Research

3D Biology | Molecular DevicesBiotechnology Research

Molecular Devices China生物技术研究

High-Content Imaging & Analysis | Molecular DevicesBiotechnology Research

Loading…

Molecular Devices Similar Companies

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Loading…

NEWS

Molecular Devices CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 31, 2025 06:26 AM

IISc Develops Molecular-Scale Technology that Mimics Brain Functions

Scientists at the Indian Institute of Science have developed molecular-scale electronic devices capable of performing multiple computing functions within...

Read Article

November 19, 2025 08:00 AM

Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry

Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility.

Read Article

March 18, 2025 07:00 AM

Quantum Computing Explained

These computers work by harnessing quantum physics — the strange, often counterintuitive laws that govern the universe at its smallest scales...

Read Article

April 11, 2024 07:00 AM

New molecular device could revolutionise medical and material engineering

Scientists from The University of Manchester have developed a first-of-its-kind molecular device that uses force to control the release of multiple small...

Read Article

September 03, 2021 07:00 AM

Groundbreaking brain-inspired memory device for semiconductor design

Researchers at the NUS have developed a novel brain-inspired device that could facilitate the transformation of semiconductor design.

Read Article

August 12, 2021 07:00 AM

Katie Sautter: building materials for a quantum future

In graduate school, Argonne postdoctoral researcher Katie Sautter learned to master a machine that builds bits of matter one atomic layer at...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-63261

SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). A low-privileged authenticated user can send a specially crafted request to a Kibana machine learning feature, causing the server to exhaust available memory and become unavailable to all users.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-72/388575

CVE-2026-63260

SUMMARY

Uncontrolled Resource Consumption (CWE-400) in Kibana can lead to denial of service via Excessive Allocation (CAPEC-130). An authenticated attacker with low-privilege access can trigger a denial of service condition in Kibana by sending a specially crafted, oversized request payload. Processing this user-supplied input requires resource-intensive memory allocation that can exhaust the available heap memory in the Kibana process, causing it to crash and become unavailable to all users.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-71/388574

CVE-2026-63259

SUMMARY

Authorization Bypass Through User-Controlled Key (CWE-639) in Kibana can lead to information disclosure via user-supplied identifiers that reference scheduled query result data from Kibana Spaces the requester is not authorized to access.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-9-4-4-security-update-esa-2026-70/388573

CVE-2026-63145

SUMMARY

Incorrect Authorization (CWE-863) in Kibana can lead to integrity compromise of Machine Learning audit and notification records via Accessing Functionality Not Properly Constrained by ACLs (CAPEC-1). A vulnerability exists in Kibana's Machine Learning functionality where a Machine Learning management endpoint performs an insufficient authorization check. The endpoint validates only a coarse privilege level but does not verify that the requesting user has access to the specific Machine Learning job or notification resources provided in the request. As a result, a low-privileged user with Machine Learning access in any Kibana space can manipulate Machine Learning audit and notification records for arbitrary jobs—including jobs in other spaces or belonging to other users—by leveraging Kibana's internally elevated credentials to write to restricted Machine Learning system indices that the user cannot access directly.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:L/A:N

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/kibana-8-19-19-9-3-8-9-4-4-security-update-esa-2026-69/388572

CVE-2026-63144

SUMMARY

Uncontrolled Recursion (CWE-674) in Elasticsearch can lead to denial of service via a specially crafted search request submitted by a low-privileged authenticated user. A user with read-level index access can submit a request that triggers unbounded recursive processing within the Elasticsearch query evaluation component, causing a fatal error that terminates the affected node. In single-node deployments, this results in complete service outage; in multi-node clusters, it causes repeated node restarts and sustained availability degradation.

Published

Date2026-07-21

Updated

Date2026-07-21

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

https://discuss.elastic.co/t/elasticsearch-8-19-19-9-3-8-9-4-4-security-update-esa-2026-68/388571

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…